Pharma: 89 stocks

Drug makers sell medicines under patents that last about 20 years. Their sales turn on new approvals, on patents running out, and on the prices that insurers pay.

As of Monday's close · Live for Pro members at the open

Pharma: 89 stocks
StockPriceQuality Score

Not scored, each with a page of its filings: ALZN, BYSI, CDT, CGC, CLNN, IMNN, JAGX, LGVN, MDWD, MTEX, NTHI, NXTS, and SCNX.

86 more ranked, for Pro members. See them free →

Tested. Our top-⁠scored stocks returned 2.2x the average stock over the next month. How we tested it

We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live, with prices that refresh every 2.5 seconds while the market is open.

See all 89 stocks rankedSee it live, free until Wednesday morning. No account. No card. Then keep going with a free account.

Why pharma stocks are up this week

Pharma stocks rose a median 1.7% from Oct 19 to Oct 26 (89 stocks); the S&P 500 fell 0.1%.

What moved them

  • No single story: 57 of 89 rose this week.
3 stocks' stories, for Pro members. See them free →

Questions about pharma

Why are pharma stocks up this week?

Pharma stocks rose a median 1.7% from Oct 19 to Oct 26 (89 stocks); the S&P 500 fell 0.1%. No single story: 57 of 89 rose this week.

Which pharma stocks rose most this week?

Myriad Genetics (MYGN) rose 43%, Liquidia (LQDA) rose 28%, and Xencor (XNCR) rose 26%.

What are the biggest companies in pharma?

The biggest by market cap are Eli Lilly (LLY) at $1.2T, Johnson & Johnson (JNJ) at $644B, and AbbVie (ABBV) at $504B.

Which companies in pharma does Breakaway rank highest?

Genmab (GMAB) 20, AbbVie (ABBV) 20, and Eli Lilly (LLY) 18, the highest Quality Scores of the 89. Breakaway ranks every stock by its Quality Score, which reads each company's numbers and its chart; the ranking is information, not advice, and each stock's page shows the reasons behind its score.

Our top-scored stocks' record: Oct 2021 to Sep 2026, before costs; recorded live since Sep 9 2026.

Breakaway publishes impersonal securities research and analytical tools: one formula, the same score for everyone. It is not personalized investment advice, and nothing here is a recommendation to buy or sell any security.

Market data from a licensed vendor. The age of every quote is shown on the page.

This browser is too old to show this page right. Update it, or open this page in Safari or Chrome.